General Information of DTT (ID: TTMS7KP)

DTT Name Protein-tyrosine phosphatase 1B (PTP1B) DTT Info
Gene Name PTPN1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
4 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
IONIS-PTP1BRX DMGTJUP Type-2 diabetes 5A11 Phase 2 [1]
TTP-814 DMH9RGV Diabetic complication 5A2Y Phase 1/2 [2]
KQ-791 DMK0BTN Type-2 diabetes 5A11 Phase 1 [1]
Trodusquemine DMQ7UN6 Breast cancer 2C60-2C65 Phase 1 [3]
------------------------------------------------------------------------------------
1 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
JTT-551 DM48HVI Type-2 diabetes 5A11 Terminated [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Protein tyrosine phosphatase 1B (PTP-1B; PTPN1). SciBX 5(7); doi:10.1038/scibx.2012.176. Feb. 16 2012
3 Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice. Obesity (Silver Spring). 2010 Aug;18(8):1516-23.
4 Pharmacological effects of JTT-551, a novel protein tyrosine phosphatase 1B inhibitor, in diet-induced obesity mice. J Diabetes Res. 2014;2014:680348.